Management of Adult Patients with Acute Leukemias and Myeloid Neoplasms in the COVID-19 Era

The podcast episode discusses the management of adult patients with acute leukemias and myeloid neoplasms during the COVID-19 pandemic. The panel of experts explores various topics, including reducing the risk of COVID-19 infections, the impact on clinical trial participation and resource allocation, and the management of patients with specific hematologic malignancies like ALL, CML, MPNs, MDS, and AML. The discussion highlights the challenges faced in making treatment decisions with limited evidence, the importance of individualizing care based on geographic factors, and the potential use of existing therapies for COVID-19. Overall, the episode emphasizes the need for ongoing adaptation, collaboration, and prioritization in the care of hematologic malignancy patients during the pandemic.